Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

Boston Scientific diskutieren

Boston Scientific

WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /

74,00 €
0,68 %

Einschätzung Buy
Rendite (%) 8,03 %
Kursziel 83,95
Veränderung
Endet am 25.04.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at UBS Group AG from $74.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,03 %
Kursziel 79,29
Veränderung
Endet am 25.04.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Mizuho from $80.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,82 %
Kursziel 76,49
Veränderung
Endet am 25.04.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Royal Bank of Canada from $78.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,82 %
Kursziel 79,29
Veränderung
Endet am 25.04.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Raymond James from $73.00 to $85.00. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,82 %
Kursziel 76,37
Veränderung
Endet am 25.04.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at JPMorgan Chase & Co. from $72.00 to $82.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,25 %
Kursziel 73,05
Veränderung
Endet am 26.04.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Barclays PLC from $70.00 to $78.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,03 %
Kursziel 82,85
Veränderung
Endet am 15.05.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Mizuho from $85.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,47 %
Kursziel 80,27
Veränderung
Endet am 22.05.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $85.00 to $87.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,47 %
Kursziel 87,33
Veränderung
Endet am 28.05.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Argus from $80.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Boston Scientific Co. (NYSE: BSX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,50 %
Kursziel 76,35
Veränderung
Endet am 18.06.25

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $82.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,50 %
Kursziel 75,42
Veränderung
Endet am 02.07.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Evercore ISI from $78.00 to $81.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,96 %
Kursziel 82,64
Veränderung
Endet am 11.07.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $87.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,50 %
Kursziel 84,40
Veränderung
Endet am 16.07.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Morgan Stanley from $79.00 to $92.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,50 %
Kursziel 77,06
Veränderung
Endet am 16.07.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at BTIG Research from $80.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,07 %
Kursziel 79,24
Veränderung
Endet am 25.07.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Needham & Company LLC from $82.00 to $86.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,07 %
Kursziel 83,85
Veränderung
Endet am 25.07.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Robert W. Baird from $90.00 to $91.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,47 %
Kursziel 78,38
Veränderung
Endet am 25.07.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at JPMorgan Chase & Co. from $82.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,47 %
Kursziel 78,23
Veränderung
Endet am 25.07.25

Boston Scientific Co. (NYSE: BSX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $85.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,47 %
Kursziel 83,73
Veränderung
Endet am 25.07.25

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Raymond James from $85.00 to $91.00. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat